Proshares Trust (ZBIO) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to 0.61.
- Zenas BioPharma's Equity Ratio fell 3153.43% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61, marking a year-over-year decrease of 3153.43%. This contributed to the annual value of 0.84 for FY2024, which is 12551.01% up from last year.
- According to the latest figures from Q3 2025, Zenas BioPharma's Equity Ratio is 0.61, which was down 3153.43% from 0.82 recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Equity Ratio ranged from a high of 0.89 in Q3 2024 and a low of 3.31 during Q4 2023
- Its 3-year average for Equity Ratio is 0.12, with a median of 0.83 in 2025.
- In the last 5 years, Zenas BioPharma's Equity Ratio surged by 12551.01% in 2024 and then tumbled by 3153.43% in 2025.
- Quarter analysis of 3 years shows Zenas BioPharma's Equity Ratio stood at 3.31 in 2023, then surged by 125.51% to 0.84 in 2024, then decreased by 27.77% to 0.61 in 2025.
- Its Equity Ratio stands at 0.61 for Q3 2025, versus 0.82 for Q2 2025 and 0.85 for Q1 2025.